Wnt signaling is important in organogenesis, and aberrant signaling in mature cells is associated with tumorigenesis. Several members of the Wnt family of signaling molecules are expressed in the developing pituitary gland. Wnt5a is expressed in the neuroectoderm that induces pituitary gland development and has been proposed to influence pituitary cell specification. We discovered that mice deficient in Wnt5a display abnormal morphology in the dorsal part of the developing pituitary. The expression of downstream effectors of the canonical Wnt pathway is not altered, and expression of genes in other signaling pathways such as Shh, Fgf8, Fgf10 and Fgfr2b is intact. Prop1 and Hesx1 are also important for normal shape of the pituitary primordium, but their expression is unaltered in the Wnt5a mutants. Specification of the hormone-producing cell types of the mature anterior pituitary gland occurs appropriately. This study suggests that the primary role of Wnt5a in the developing pituitary gland is in establishment of the shape of the gland. q
Introduction
The pituitary gland originates from two embryonic tissue layers. The posterior lobe of the pituitary arises from neural ectoderm and eventually secretes oxytocin and vasopressin, while both the anterior and intermediate lobes arise from oral ectoderm. The anterior lobe of the mature pituitary gland contains five cell types that are specialized in the production of growth hormone (GH, somatotropes), thyroidstimulating hormone (TSH, thyrotropes), prolactin (PRL, lactotropes), adrenocorticotropin (ACTH, corticotropes), and the gonadotropins (luteinizing hormone, LH, and follicle stimulating hormone, FSH; gonadotropes). The intermediate lobe contains melanotropes that process proopiomelanocortin (POMC) into melanocyte-stimulating hormone and endorphins. Early pituitary gland development and cell specification are conserved among vertebrates and have been most extensively studied in the mouse. Specification of the cell types in the anterior and intermediate lobes occurs from approximately embryonic day 10.5 (e10.5) through e17.5 in the mouse and requires the action of a number of signaling molecules and transcription factors. Opposing gradients of bone morphogenetic proteins (BMPs) from the ventral mesenchyme and fibroblast growth factors (FGFs) from the dorsal infundibulum are necessary for cell specification of the thyrotropes and corticotropes. These gradients establish region-specific expression of the LIM homeobox transcription factors LHX3 and ISL1 that are critical for cell fate determination (Ericson et al., 1998) . Later in development, the PIT1 lineage is activated by the transcription factor PROP1, which is necessary for expansion of thyrotrope, somatotrope, and lactotrope populations and for gonadotrope function (Gage et al., 1996b; Tang et al., 1993) .
The shape of the developing pituitary is affected by a number of transcription factors and signaling molecules, including PROP1 (Gage et al., 1996a; Raetzman et al., 2002) . The mechanism of shape regulation is unknown, although it is likely to involve dorsal -ventral signaling gradients, the expression of downstream transcription factors, and physical forces exerted by other structures in the embryo. The shape of the organ differs somewhat among vertebrates, although the shape is remarkably consistent among individuals of a single species (Dubois et al., 1997; Mikami, 1992; Sasaki et al., 2003; Sasaki and Nishioka, 1998) . One of the earliest initiating events in pituitary development is the exclusion of sonic hedgehog (SHH) from the area of the oral placode destined to invaginate as Rathke's pouch (Treier et al., 2001) . Abnormalities in SHH signaling appear to influence pituitary growth more than shape (Treier et al., 2001) . Imbalances in FGF signaling disrupt normal pituitary shape, with overexpression of FGF8 leading to branching dysmorphology by day e18.5 (Treier et al., 1998) . Dramatic dysmorphology is caused by Hesx1 or Prop1 deficiencies. HESX1 deficiency often causes the pituitary to be displaced rostrally and exhibit severe dysmorphology by day e12.5 (Dattani et al., 1998; our unpublished observations) . In Prop1 df/df pituitaries, abnormal dorsal shape is evident later, by day e14.5, and is accompanied by deficits in the more ventrally located hormone-producing cell types (Raetzman et al., 2002) . This suggests that pituitary gland shape is regulated at multiple stages during ontogeny by the action of multiple genes.
Wnt signaling is essential for proper growth and development of vertebrates and invertebrates (Cadigan and Nusse, 1997) . Members of the large vertebrate family of Wnt molecules have complex and sometimes overlapping expression patterns, but their unique roles are illustrated by the phenotypes of mice with specific alterations in Wnt signaling. Other components of Wnt signaling also profoundly affect development, as illustrated by the phenotypes of mice lacking the Wnt inhibitor DKK1 (Mukhopadhyay et al., 2001) , Wnt co-receptor LRP6 (Pinson et al., 2000) , the canonical Wnt signaling molecule b-catenin (Brault et al., 2001) , and the TCF/LEF family of transcription factors that are induced by canonical Wnt signaling (Korinek et al., 1998) . Several lines of evidence support the idea that Wnt signaling is involved in the development of the pituitary gland. Multiple downstream members of the canonical Wnt pathway, including FZD2, TCF4, groucho-related genes, b-catenin and APC, were found in the developing pituitary at e14.5, which is just prior to the appearance of many differentiated cell types (Douglas et al., 2001) . The requirement for some of these factors, especially Tcf4 (Tcf7l2) and groucho-related gene 5 (Aes) was confirmed by analysis of knockout mice (Brinkmeier et al., 2003) . Recent studies suggest that canonical Wnt signaling is important for the function of the transcription factor PITX2, although the specific Wnts that are involved remain unknown (Kioussi et al., 2002) .
Wnt4 is expressed in Rathke's pouch, a part of the oral ectoderm that later becomes the intermediate and anterior lobes of the pituitary gland (Treier et al., 1998) . In the absence of WNT4, populations of somatotropes and thyrotropes, as well as cells secreting aGSU, are slightly decreased in the anterior pituitary gland at e17.5, suggesting a role for WNT4 in differentiation or expansion of committed cell types within the anterior lobe. Expression of Wnt5a has been reported in the ventral diencephalon, which is known to be critical for induction of differentiation of Rathke's pouch (Treier et al., 1998) . Although the role of WNT5A has not been investigated in detail, explant studies suggest that WNT5A, together with BMP4, has profound effects on differentiation of early aGSU-expressing cells by influencing cell fate determination (Treier et al., 1998) . This observation has led to acceptance of an important role for WNT5A in cell specification (Dattani and Robinson, 2000) .
Embryonic deficiency of WNT5A has demonstrated an unequivocal role for WNT5A in many outgrowing embryonic structures, preventing their extension from precursor tissues, and results in neonatal lethality (Yamaguchi et al., 1999) . Among the affected structures are the snout, mandible, limbs, and genital tubercle (Yamaguchi et al., 1999) . In this study, we tested the requirement for WNT5A in pituitary development and demonstrate that the shape of the developing pituitary is altered by WNT5A deficiency. Surprisingly, this dysmorphology is not accompanied by obvious changes in the known set of critical transcription factors or signaling molecules, nor by a failure to specify the hormone-producing cells of the anterior lobe. This proves that Wnt5a is dispensable for cell specification in intact animals, despite its profound effect on explants. Our study reveals that the unique role of Wnt5a in the developing pituitary gland is primarily to establish the shape of the gland.
Results

Abnormal dorsal pituitary morphology occurs in Wnt5a
2/2 mice Wnt5a is expressed in the developing infundibulum, which is known to be essential for pouch induction (Treier et al., 1998; Takuma et al., 1998) . To assess the role of WNT5A in pituitary organogenesis we analyzed WNT5A deficient mice that were previously described (Yamaguchi et al., 1999) . Initiation of the pouch structure at day e10.5 is nearly normal (data not shown). By day e11.5 of development, abnormal branching of the dorsal pouch is striking (Fig. 1, arrowheads) . The anterior lobe appears at e12.5, and in contrast to the dorsal pouch, it appears similar to wildtype in morphology, as does the invaginating infundibulum (arrow) and surrounding mesenchyme. Dorsal dysmorphology and apparently normal anterior lobe formation are also evident at day e14.5. By day e18.5, dysmorphology is less conspicuous, although the intermediate lobe still appears abnormal. The morphology of the posterior lobe of the gland is unaffected. Abnormal evagination of the infundibulum could influence pouch development, but parasagittal sections lacking the infundibulum also display dysmorphology (data not shown), suggesting the infundibulum must exert long-ranging effects if it is the primary cause.
Cell specification is intact in the Wnt5a
2/2 pituitary Mutations in several molecules important in pituitary development can lead to specific deficiencies in the hormone-producing cell populations in addition to dysmorphology. Prop1 df/df mice, for example, exhibit dysmorphology 2 days later than Wnt5a 2/2 mice and have profound anterior lobe hypoplasia due to failure of the entire PIT1 lineage, which is composed of thyrotropes, somatotropes, and lactotropes (Gage et al., 1996a,b) . We investigated cell specification of the WNT5A mutant pituitary gland at day e18.5 with antibodies that recognize hormones produced by specific cell populations. Due to neonatal lethality of the Wnt5a 2/2 mice, this is the latest time at which we can investigate cell specification. No differences in hormone staining were seen between wild type and WNT5A deficient pituitaries at this age ( Fig. 2C -L) . Antibodies to aGSU, the a subunit common to gonadotropins and thyrotropin, are expected to stain both thyrotropes and gonadotropes. aGSU expression appeared unchanged at day e12.5 ( Fig. 2A,B ) and e18.5 (Fig. 2C,D) . Antibodies to POMC labeled presumed melanotropes of the intermediate lobe and corticotropes of the anterior lobe similarly in mutant and wild-type pituitaries at day e18.5 ( Fig. 2E,F) and earlier, at day e14.5 (data not shown). Populations of cells expressing GH, LHb and TSHb were found in the anterior lobe in similar proportions and positions in the Wnt5a 2/2 mice and their wild-type littermates ( Fig. 2G -L) (Japon et al., 1994; Simmons et al., 1990) .
Previous studies demonstrated that the combination of BMP4 and WNT5A, but not BMP4 alone, could induce aGSU expression in pituitary explants, suggesting a potential role for WNT5A in aGSU expression (Treier et al., 1998) . However, no differences were seen in aGSU expression between wild-type and WNT5A mutant pituitaries. These results are similar to those seen with mice deficient in Hesx1 in that mutant pituitaries are dysmorphic but capable of cell specification (data not shown and Dasen et al., 2001 ).
Alterations in proliferation and cell death do not readily explain dysmorphology
Little cell division is observed in the infundibulum or posterior pituitary lobe during ontogeny, but cell proliferation is evident in the primordium from which the anterior and intermediate pituitary lobes develop (Carbajo-Perez et al., 1989; Carbajo-Perez and Watanabe, 1990; Ikeda and Yoshimoto, 1991; Raetzman et al., 2002) . The proliferating cells are concentrated in the periluminal area of Rathke's pouch, with the highest mitotic index in the dorsal tip of the pouch. As the cells of the primordium take on a glandular appearance, they no longer divide, suggesting cells must cease proliferation in order to differentiate. We hypothesized that the dorsal dysmorphology in WNT5A mutants might be attributable to effects on the transition of proliferating progenitor cells in the periluminal area of Rathke's pouch to quiescent differentiated cells in the prospective anterior lobe. This hypothesis is supported by evidence that an increase in progenitor cell proliferation can result in distorted shape of the neural epithelium (Chenn and Walsh, 2002) , as well as recent evidence that WNT5A affects cytokine-induced proliferation of precursor cells in blood cell differentiation (Liang et al., 2003) . To test this idea we used antibodies directed against Ki67, which is a general marker of participation in the cell cycle; phosphorylated histone H3, which is only present during M phase; and bromodeoxyuridine (BrdU), a thymidine analog that can be incorporated into DNA replication, which occurs in S phase. We injected pregnant dams with BrdU at e10.5, e11.5 or e12.5, and analyzed BrdU-labeled cells in the pituitaries of wild-type and WNT5A mutant mice on the day of injection (90 min following) or 24 h later. There appeared to be no differences in the location or gross quantity of BrdU (Fig. 3A,B) or Ki67 (Fig. 3C,D) labeled cells. Changes in the rate of exit from the cell cycle in Wnt5a mutants, as represented by the fraction of 24 h BrdU-labeled cells that are also labeled with Ki67 (Fig. 3C,D) , were not statistically significant. Phosphohistone H3 gave equivalent results (data not shown). Theoretically, alterations in cell death could contribute to the dysmorphology of the periluminal area in WNT5A mutant mice, but there is very little detectable cell death in the developing pituitary normally, making this an unlikely possibility. TUNEL staining did not reveal any decrease in apoptotic cells in the mutants at e12.5 or e14.5 ( Fig. 3E-H ).
Expression of signaling molecules is intact in Wnt5a 2/2 pituitaries
The correct spatial and temporal pattern of expression of signaling molecules is required for pituitary gland development. These signals are produced by the oral ectoderm, Fig. 3 . Detection of cell death and proliferation. To assess cell proliferation, BrdU was injected into pregnant dams 90 min (A, B) or 24 h (C, D) prior to embryo removal at day e12.5. BrdU is incorporated into cells undergoing DNA synthesis and therefore is a marker of cells in S phase. In panels A and B, BrdU is labeled in green, with DAPI nuclear counterstain in blue. In panels C and D, BrdU is labeled in red, and sections were counterstained with an antibody to Ki67, which labels dividing cells in all phases of the cell cycle. Ki67 was detected using a green fluorophor. Yellow cells (arrow) are those which are double-labeled with both BrdU and Ki67. Sagittal sections of embryos at days e12.5 (E, F) and e14.5 (G, H) were probed using the TUNEL approach to detect evidence of cell death. Cells undergoing apoptosis are labeled in green (arrow). DAPI nuclear counterstain (blue) was used to highlight morphology. Fig. 4 . Detection of signaling molecules important in pituitary development. Sagittal sections of embryos at day e10.5 (A, B), e12.5 (C-J), or e14.5 (K, L) were probed to detect several signaling molecules known to be important to pituitary development. Antibodies were used to detect SHH (A, B), FGFR2b (G, H), Ecadherin (I, J) and Notch2 (K, L), and in situ hybridization was used to detect Fgf10 (C, D) and Fgf8 (E, F) transcripts. No differences in the expression patterns of these molecules were noted. SHH expression is excluded from the caudal aspect of Rathke's pouch (brackets). Antibodies to E-cadherin, a transmembrane epithelial adhesion molecule, and Notch2, a cell adhesion molecule altered in Prop1 df/df animals, also revealed no difference in expression patterns in the Wnt5a 2/2 pituitary (I-L).
ventral diencephalon, surrounding mesenchyme, and within the gland itself (Dasen and Rosenfeld, 1999) . Alterations in a number of signaling molecules have been shown to disturb pituitary development. For example, mice that lack the infundibulum or the FGF10 signal coming from it exhibit agenesis of the anterior and intermediate pituitary lobes (Ohuchi et al., 2000) , and overexpression of FGF8 can lead to abnormal branching of the pituitary primordium (Treier et al., 2001) . The expression of Wnt5a in the infundibulum, and the requirement of the infundibulum for survival of Rathke's pouch, suggested the possibility that Wnt5a deficiency might be accompanied by inappropriate regulation of other signaling molecules. Using an antibody to SHH, we demonstrated appropriate exclusion of this signal from the invaginating Rathke's pouch at day e10.5 in the Wnt5a mutant pituitaries (Fig. 4A,B) . In situ hybridization experiments demonstrated intact expression of Fgf8 and Fgf10 in the infundibulum and the FGF receptor FGFR2B in the pouch at day e12.5 ( Fig. 4C -H ). This suggests that Wnt5a deficiency does not grossly affect expression of these molecules. The periluminal cells of Rathke's pouch are much more closely packed than the differentiating cells in the developing anterior lobe, suggesting that repression of cell adhesion may be an important aspect of pituitary development. The molecules that are involved in maintaining the tight junctions in the pituitary are not known, although the epithelial adhesion molecule E-cadherin is normally expressed in this area. Brain expression of E-cadherin has been shown to be upregulated in Wnt1 mutants (Shimamura et al., 1994) . No differences were noted in the expression of E-cadherin in the pituitaries of wild-type and Wnt5a-deficient mice (Fig. 4I,J) . However, there are many cell adhesion molecules expressed in the developing pituitary (Carninci et al., 2003) , and it is daunting to pinpoint which are influenced by WNT5A deficiency. We expected that the dysmorphic character of other mutants would provide a common clue. Recent studies in Prop1 mutants suggest that Notch2 could be involved in pituitary shape and/or cell specification (Raetzman et al., 2003) . We examined Notch2 and found no change in expression (Fig. 4K,L) . Thus, the etiology of the dysmorphology is unknown.
Expression of critical transcription factors is preserved in Wnt5a
2/2 pituitaries Opposing dorsal -ventral gradients of FGF and BMP expression from the infundibulum and ventral mesenchyme are essential for establishing the dorsalized expression of LHX3 and ventral-specific expression of ISL1 (Ericson et al., 1998) . The spatially restricted expression of these transcription factors is essential for specification of the first two lineages that arise, namely rostral tip thyrotropes and corticotropes. We examined Wnt5a 2/2 pituitaries for evidence of defects in early dorsal -ventral patterning. LHX3 and ISL1 expression patterns (Fig. 5A -D) , however, appeared intact. We expect there may be other proteins differentially expressed on the dorsal -ventral axis that contribute to the dysmorphology characteristic of Wnt5a mutants.
Like Wnt5a mutants, Hesx1 and Prop1 mutants display significant dorsal dysmorphology in the developing pituitary (Dattani et al., 1998; Gage et al., 1996b; Sornson et al., 1996) . Prop1 df/df mice display inappropriately late waning of Hesx1 expression (Gage et al., 1996a) , and Prop1 expression appears intact in Hesx1 2/2 mice (Dasen et al., 2001 ; and data not shown). This places Prop1 downstream of Hesx1. To determine the placement of Wnt5a in this pathway, we examined the expression of Hesx1 and Prop1 transcripts in the Wnt5a 2/2 mice. No differences in expression were noted at day e12.5 for Hesx1 (Fig. 5E,F) , and transcripts were extinguished appropriately by day e14.5 (data not shown). Similarly, Prop1 expression appeared intact in Wnt5a 2/2 pituitaries at day e12.5 ( Fig. 5G,H ) and throughout the remainder of gestation (data not shown). This suggests that Hesx1 and Prop1 expression are not dependent upon WNT5A signaling.
Wnt signaling triggers an intracellular cascade that can result in altered transcription of downstream genes. WNT5A has been shown to signal through both canonical and non-canonical pathways (Slusarski et al., 1997a; Holmen et al., 2002; Liang et al., 2003) . Multiple lines of evidence suggest that canonical Wnt signaling is important in pituitary development. Downstream members of the canonical Wnt signaling pathway, including the transducer like enhancer of split family (TLE, also known as GRG), amino terminal enhancer of split (AES), and the transcription factor TCF4 (officially known as Tcf7l2), are implicated in pituitary development (Brinkmeier et al., 2003; Dasen et al., 2001) . Therefore, we investigated the expression patterns of these factors in the pituitaries of mice deficient in WNT5A. No apparent differences were seen in b-catenin expression at days e12.5 and e14.5 (data not shown). We found TLE3 expression appropriately restricted to the dorsal gland at day e14.5 in wild-type and Wnt5a 2/2 pituitaries and noted no differences in ventral TCF4 expression at e14.5 (Fig. 5I -L) . PITX2 has recently been suggested to be a target of Wnt signaling in pituitary cells because it is activated by b-catenin and regulates growth through enhancing transcription of cyclin D2 (Kioussi et al., 2002) . No differences were seen in Pitx2 or cyclin D2 expression in Wnt5a mutants at e12.5 ( Fig. 5M -P) . Thus, these critical players in development are unaltered by WNT5A deficiency.
Discussion
Wnt5a is expressed during development in many structures that grow out from the primary body axis, including limbs, snout, and genital tubercle, and Wnt5a deficiency is associated with profound growth defects in these organs (Yamaguchi et al., 1999) and in the hematopoietic system (Liang et al., 2003) . Wnt5a is expressed in the ventral diencephalon adjacent to the developing pituitary (Treier et al., 1998) . We report here that Wnt5a deficiency affects pituitary shape. Allocation to different anterior pituitary cell fates appears normal, but the dysmorphology persists in the intermediate lobe.
The mechanism of WNT5A action in the pituitary is unknown. WNT5A may signal through the canonical Wnt pathway or take advantage of alternative signaling mechanisms such as the Wnt/Ca 2þ pathway (Liang et al., 2003; Slusarski et al., 1997b) . Because overexpression of b-catenin in neural precursors causes overgrowth and dysmorphology of the neural epithelium (Chenn and Walsh, 2002) , it is tempting to speculate that alterations in canonical Wnt signaling could cause overgrowth and dysmorphology of Rathke's pouch. We did not see differences in the expression of a number of downstream members of the canonical Wnt pathway in Wnt5a mutants, however. The stunting of proximal -distal growth in the limbs and trunk of Wnt5a-deficient animals is accompanied by a decrease in the number of proliferating cells (Yamaguchi et al., 1999) . Although we did not detect remarkable differences in the initial invagination of Rathke's pouch, or in cell death or proliferation in the developing pituitary, we cannot rule out subtle changes in proliferation or the rate of exit from cell cycling, which could contribute to dysmorphology of the periluminal area where proliferation occurs (Raetzman et al., 2002) . In the hematopoietic system of Wnt5a-deficient animals, precursor cells fail to respond to cytokine stimulation of proliferation, an effect mediated by the non-canonical Wnt/Ca 2þ signaling pathway (Liang et al., 2003) . Future studies will address the impact of Wnt5a deficiency on non-canonical Wnt signaling pathways in the pituitary.
Animals deficient in transcription factors Hesx1 and Prop1 also exhibit severe pituitary dysmorphology. Hesx1 is widely expressed in the developing brain (Hermesz et al., 1996) , and in Hesx1 2/2 mice, abnormal bifurcations and irregular location of Rathke's pouch occur by e12.5, suggesting that early steps in pouch invagination are affected, such as SHH signaling. In addition, Hesx1 deficiency causes severe midline defects, including defects in the infundibulum and hypothalamus (Dattani et al., 1998) . Therefore, the pituitary dysmorphology characteristic of Hesx1 mutant animals is likely to be attributable to extrinsic as well as intrinsic influences on pituitary development. The abnormal dorsal dysmorphology of In situ hybridization was used to detect Hesx1 (E, F), Prop1 (G, H), and Pitx2 (M, N) transcripts, which are required for normal pituitary shape and development. No differences in the expression patterns of these molecules were noted. The dorsal-ventral gradients of expression characteristic of LHX3 and ISL1 were normal (brackets).
the Prop1 df/df pituitary appears later in development than that of Hesx1 or Wnt5a mutant animals, and in contrast to those models, Prop1 deficiency is accompanied by reductions in cell populations of the anterior pituitary. This, and the fact that Prop1 is expressed normally in Wnt5a mutants, demonstrate that Prop1 is not a simple downstream target of Wnt5a signaling either, although they may both feed into the pathway that regulates growth of the periluminal cells.
Organ shape is influenced by many extrinsic and intrinsic forces, and organs demonstrate remarkably consistent shape between individuals of a particular species. The mechanism by which the convoluted shape of Rathke's pouch in Wnt5a, Prop1, and Hesx1 mutants arises is unknown. Given the differences in marker gene expression among these mutants, it seems likely that different mechanisms underlie the dysmorphology in each case. The dysmorphology in Hesx1 mutants is likely due to a failure to specify the midline appropriately, whereas evidence suggests that canonical Wnt signaling is affected in Prop1 (Brinkmeier et al., 2003) but not Wnt5a mutants. Remarkably, the dysmorphic features of Wnt5a-deficient mouse pituitaries are highly analogous to the normal shape of the dog pituitary (Sasaki and Nishioka, 1998) . This suggests that changes in Wnt signaling could contribute to the evolution of different organ shapes among species.
The pituitary phenotype of mice deficient in Wnt5a is mild compared to the effects of Wnt5a deficiency in other organs where it is expressed, such as the limbs (Yamaguchi et al., 1999) . This is surprising, given that pituitary explants require WNT5A to grow and differentiate in response to BMP (Treier et al., 1998) . The difference between the in vivo and in vitro requirements for WNT5A suggests that its role in the pituitary may overlap with the roles of other Wnt signaling molecules there. Embryonic pituitary expression patterns of most members of the large Wnt signaling family are not known, but Wnt4 expression in the developing pituitary appears to overlap somewhat with that of Wnt5a. Wnt4 and Wnt5a are also both expressed in mammary tissue (Weber-Hall et al., 1994) , where ductal branching is a component of the functional differentiation of the mammary gland. Analysis of Wnt4-deficient mammary tissue during pregnancy revealed an early decrease in ductal branching that resolved later in pregnancy, possibly due to compensation from other Wnt signaling molecules including WNT5A (Brisken et al., 2000) . Therefore, WNT4 is a good candidate for functional overlap with WNT5A in vivo. A similar role for Wnt4 in cell differentiation in the pituitary gland is supported by the observed decrease in the differentiation of specific cell types in its absence (Treier et al., 1998) . If WNT5A contributes to differentiation in the pituitary, however, its contribution is not required, because in the absence of WNT5A, committed cells are still seen by the time of birth. We suspect that WNT4, WNT5A and one or more of the other 17 Wnt family members have functional overlap in regulation of pituitary growth and differentiation.
Alterations in Wnt5a expression have been implicated in a number of human cancers and seem to be accompanied by changes in cell adhesion. Upregulation of Wnt5a expression has been noted in cancers of the breast, lung, and prostrate, whereas it is downregulated in pancreatic cancer (Crnogorac-Jurcevic et al., 2001; Iozzo et al., 1995; Lejeune et al., 1995) . Cell shape changes occur upon downregulation of Wnt5a in a number of mammary epithelial cell lines, potentially reflecting a disruption in cell adhesion and interaction with extracellular matrix (Bui et al., 1997; Huguet et al., 1995; Jonsson and Andersson, 2001) . In melanoma cells, overexpression of WNT5A was accompanied by actin reorganization and increased cell adhesion, as well as increased cellular motility (Weeraratna et al., 2002) . In the pituitary, Wnt5a may stimulate changes in cell adhesion that permit periluminal cells to be released and migrate to their appropriate positions in the developing anterior lobe. In the absence of Wnt5a, this process could be delayed until Prop1 expression stimulates it, allowing the dysmorphology to diminish by late gestation. Early differences in the periluminal proliferative area in both Wnt5a and Prop1 mutant mice might increase the risk of adenomas later in life. Both increased and decreased levels of PROP1 can cause pituitary adenomas. The role of WNT5A in these very common intracranial tumors has not been examined (Burrow et al., 1981; Cushman et al., 2001; Riepe et al., 2001) , but WNT5A appears to act as a tumor suppressor in hematopoietic tissue (Liang et al., 2003) and could also do so in the pituitary. Pituitary-specific disruption of WNT5A is required to address this definitively. Understanding the role that WNT5A and other Wnt signaling molecules play in development in the pituitary may contribute to a better understanding of both hormone deficiency and pituitary adenoma risk factors.
Experimental procedures
Mouse care and embryo preparation
Wnt5a mutant mice on a mixed 129Sv
Brd and C57BL/6 background were obtained from Stephen Jones (Yamaguchi et al., 1999) and maintained at the University of Michigan by heterozygote matings. All procedures were approved by the University of Michigan Committee on Use and Care of Animals and were in compliance with the principles and procedures outlined in the NIH Guidelines for the Care and Use of Experimental Animals. Genotyping was performed with the following primers: forward, 5 0 -gacttcctggtgagggtgcgtg-3 0 for both wild-type and mutant alleles, coupled with different reverse primers: 5 0 -ggagaatgggcacacagaatcaac-3 0 for the wild-type allele and PGK insert primer 5 0 -gggagccggttggcgctaccggtgg-3 0 for the mutant allele. An annealing temperature of 62 8C was used.
Embryos were obtained by heterozygote matings. Noon on the day of vaginal plugging was designated day e0.5. DNA was prepared from the limbs or hind end of the embryo for genotyping.
Histology and immunohistochemistry
Embryos were fixed in 3.7% buffered paraformaldehyde for 1.5 h (e10.5), 2 h (e12.5), 3 h (e14.5), or 16 h (e18.5). After rinsing in PBS, samples were dehydrated to 70% ethanol and embedded in paraffin (Citadel 1000, Shandon, Cheshire, England). Samples were sectioned at 8 mm (e18.5 samples) or 6 mm (all other ages). At least three pairs of embryos ðn ¼ 3Þ were analyzed for each assay except where noted.
Sections were deparaffinized in xylene, rehydrated through a series of graded ethanol washes, and stained in hematoxylin (Fisher Scientific, Pittsburgh, PA) and eosin (Sigma, St Louis, MO) or used for immunohistochemistry or in situ hybridization. For immunohistochemistry, the following antibodies were used to detect transcription factors or signaling molecules: LHX3 (1:1000, Developmental Studies Hybridoma Bank (DSHB), University of Iowa, Iowa City, IA), ISL1 (1:600, DSHB), SHH (1:300, R&D Systems Inc., Minneapolis, MN), Notch2 (1:150, DSHB), TCF4 (a gift of Greg Dressler, University of Michigan, Ann Arbor, MI), GRG3 (1:300, Chemicon International, Inc., Temecula, CA), FGFR2 and cyclin D2 (1:400 and 1:200, respectively, Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Slides were boiled in 0.1 M citrate (pH 6.0) to unmask epitopes. For detection of hormone precursors, antibodies (aGSU 1:200, LH 1:1000, ACTH 1:1000, TSH 1:1000, GH 1:1000) were obtained from the National Hormone and Pituitary Program, and immunohistochemistry was performed as described (Kendall et al., 1994) . For detection of LHX3 ðn ¼ 2Þ; ISL1 ðn ¼ 2Þ; and pituitary hormones, biotinylated secondary antibodies were used with avidin and biotinylated peroxidase and chromagen detection was with diaminobenzidine (Sigma, St Louis, MO), which produces a brown precipitate. Sections were counterstained with Methyl green (Vector Labs, Burlingame, CA) except in the case of cyclin D2, which was counterstained with eosin. For FGFR2 ðn ¼ 2Þ; SHH, TCF4, and GRG3, the TSA-FITC System (Perkin -Elmer Life Sciences, Boston, MA) was used to amplify and detect signal.
In situ hybridization
In situ hybridization was performed on 6 mm paraffin sections using riboprobes labeled with DIG (Roche) as described (Douglas et al., 2001 ). Prop1 antisense riboprobe was generated by using T7 polymerase and a linearized clone containing the entire coding sequence, and was hybridized to sections overnight at 57 8C. An antisense Hesx1 riboprobe was generated by T7 polymerase and a 400 bp Hesx1 clone and hybridized to sections overnight at 55 8C. A plasmid containing Fgf8 was a gift from Gail Martin (Crossley and Martin, 1995) and was used to generate an Fgf8 antisense riboprobe hybridized to sections at 60 8C overnight. A plasmid containing Fgf10 was a gift from Brigid Hogan (Bellusci et al., 1997) and was used to generate an Fgf10 antisense riboprobe hybridized at 57 8C overnight. Probes generated from the sense strand were used as negative controls.
Cell death and proliferation assays
Apoptosis was assessed via the TUNEL method using the FragEL kit (Oncogene Research Products) according to the manufacturer's protocol, with cy2-conjugated streptavidin (Jackson ImmunoResearch Laboratory Inc., West Grove, PA, 1:200) detection of the signal. Nuclear counterstain 4 0 ,6-diamidino-2-phenylindole (DAPI; Molecular Probes Inc., Eugene, OR) was used to visualize the pituitary.
To assess cell proliferation, pregnant mice were injected intraperitoneally with BrdU (Fisher Scientific) at 100 mg/kg body weight either 24 h or 90 min before embryo removal. BrdU was detected as described (Raetzman et al., 2002) . Cell proliferation was also assessed using a rabbit polyclonal antibody to Ki67 (Vector Labs, 1:500). For amplification and detection of Ki67 signal, biotin-conjugated goat anti-rabbit IgG (Jackson, 1:200) and streptavidin-cy2 (Jackson, 1:200) were used. To estimate the rate of cell exit from the cell cycle in the pituitary, yellow cells (indicating co-labeling with BrdU and Ki67) were counted and divided by the sum of the red (BrdU-labeled) and yellow cells, as described (Chenn and Walsh, 2002) . Two sections each from a total of three pairs of animals at ages e11.5 (injected with BrdU at e10.5) and e12.5 (injected at e11.5) were analyzed. An unpaired t-test was applied to the results, with P , 0:05 considered statistically significant.
